Published in PLoS One on May 21, 2013
Effects of cigarette smoke on Toll-like receptor (TLR) activation of chronic obstructive pulmonary disease (COPD) macrophages. Clin Exp Immunol (2014) 0.93
The effects of corticosteroids on COPD lung macrophages: a pooled analysis. Respir Res (2015) 0.81
Corticosteroid insensitive alveolar macrophages from asthma patients; synergistic interaction with a p38 mitogen-activated protein kinase (MAPK) inhibitor. Br J Clin Pharmacol (2015) 0.80
Corticosteroid effects on COPD alveolar macrophages: dependency on cell culture methodology. J Immunol Methods (2014) 0.78
Neutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controls. Int J Chron Obstruct Pulmon Dis (2016) 0.78
Mechanisms of corticosteroid insensitivity in COPD alveolar macrophages exposed to NTHi. Respir Res (2017) 0.75
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med (2007) 19.86
The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med (2004) 17.08
Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med (2005) 6.13
Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med (1996) 5.53
Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J (2003) 5.53
Multiple control of interleukin-8 gene expression. J Leukoc Biol (2002) 5.35
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell (2005) 4.30
Combinatorial roles of nuclear receptors in inflammation and immunity. Nat Rev Immunol (2006) 3.20
The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study. Am J Respir Crit Care Med (2002) 3.05
Mediators of chronic obstructive pulmonary disease. Pharmacol Rev (2004) 2.94
FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem (2004) 2.91
Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med (2004) 2.19
Modulation of glucocorticoid receptor function via phosphorylation. Ann N Y Acad Sci (2004) 1.97
Deciphering the phosphorylation "code" of the glucocorticoid receptor in vivo. J Biol Chem (2002) 1.95
Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax (2005) 1.92
Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J (2009) 1.90
Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol Cell Biol (1997) 1.88
Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 1.85
p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J Allergy Clin Immunol (2002) 1.84
Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 1.82
Glucocorticoid receptor phosphorylation differentially affects target gene expression. Mol Endocrinol (2008) 1.81
Update on glucocorticoid action and resistance. J Allergy Clin Immunol (2006) 1.80
Corticosteroid effects on cell signalling. Eur Respir J (2006) 1.63
Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. Mol Endocrinol (2002) 1.58
p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol Endocrinol (2005) 1.52
Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa. Am J Respir Crit Care Med (1996) 1.44
Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial. Thorax (2007) 1.42
Immunophilin chaperones in steroid receptor signalling. Curr Top Med Chem (2003) 1.41
Increased activation of p38 MAPK in COPD. Eur Respir J (2007) 1.33
Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes. J Steroid Biochem Mol Biol (2008) 1.26
Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. Br J Clin Pharmacol (2001) 1.25
Ikappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma. Am J Respir Crit Care Med (2005) 1.24
The properties of inhaled corticosteroids: similarities and differences. Prim Care Respir J (2007) 1.18
Glucocorticoid sensitivity of lipopolysaccharide-stimulated chronic obstructive pulmonary disease alveolar macrophages. Clin Exp Immunol (2009) 1.13
Inhibitory effect of p38 mitogen-activated protein kinase inhibitors on cytokine release from human macrophages. Br J Pharmacol (2006) 1.13
FK506-binding protein 51 regulates nuclear transport of the glucocorticoid receptor beta and glucocorticoid responsiveness. Invest Ophthalmol Vis Sci (2008) 1.11
Synergistic effects of p38 mitogen-activated protein kinase inhibition with a corticosteroid in alveolar macrophages from patients with chronic obstructive pulmonary disease. J Pharmacol Exp Ther (2011) 1.10
Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects. Exp Physiol (2006) 1.05
Cigarette smoke extract induced cytokine and chemokine gene expression changes in COPD macrophages. Cytokine (2008) 0.95
Effect of smoking on MAP kinase-induced modulation of IL-8 in human alveolar macrophages. Eur Respir J (2004) 0.94
Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technology. Pulm Pharmacol Ther (2006) 0.91
Glucocorticoid pathways in chronic obstructive pulmonary disease therapy. Proc Am Thorac Soc (2005) 0.87
Optimum peripheral drug deposition in patients with cystic fibrosis. J Aerosol Med (2005) 0.87
The effect of different corticosteroids and cyclosporin A on interleukin-4 and interleukin-5 release from murine TH2-type T cells. Eur J Pharmacol (1994) 0.84
A homogeneous cell-based assay to measure nuclear translocation using beta-galactosidase enzyme fragment complementation. Assay Drug Dev Technol (2006) 0.83
Mortality of large trees and lianas following experimental drought in an Amazon forest. Ecology (2007) 3.61
The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines. Proc Natl Acad Sci U S A (2011) 2.38
Implementing a virtual community of practice for family physician training: a mixed-methods case study. J Med Internet Res (2014) 1.92
Drought effects on litterfall, wood production and belowground carbon cycling in an Amazon forest: results of a throughfall reduction experiment. Philos Trans R Soc Lond B Biol Sci (2008) 1.88
Ligand modulation of REV-ERBalpha function resets the peripheral circadian clock in a phasic manner. J Cell Sci (2008) 1.79
Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum (2002) 1.66
Predictors of objective cough frequency in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 1.64
Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial. Int J Chron Obstruct Pulmon Dis (2012) 1.52
Efficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studies. Int J Chron Obstruct Pulmon Dis (2010) 1.51
Drought stress and carbon uptake in an Amazon forest measured with spaceborne imaging spectroscopy. Proc Natl Acad Sci U S A (2004) 1.50
Increased airway T regulatory cells in asthmatic subjects. Chest (2010) 1.50
Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study. Eur Respir J (2012) 1.50
A comparison of lung function methods for assessing dose-response effects of salbutamol. Br J Clin Pharmacol (2004) 1.45
Case series: the McGrath videolaryngoscope--an initial clinical evaluation. Can J Anaesth (2007) 1.37
1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity. J Pharmacol Exp Ther (2007) 1.29
MUC5B is the major mucin in the gel phase of sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 1.27
CD4-regulatory cells in COPD patients. Chest (2007) 1.27
alpha,beta-Unsaturated aldehydes contained in cigarette smoke elicit IL-8 release in pulmonary cells through mitogen-activated protein kinases. Am J Physiol Lung Cell Mol Physiol (2009) 1.24
Transient receptor potential ankyrin 1 channel localized to non-neuronal airway cells promotes non-neurogenic inflammation. PLoS One (2012) 1.23
Evidence for a separate mechanism of toxicity for the Type I and the Type II pyrethroid insecticides. Neurotoxicology (2009) 1.20
Impulse oscillometry in COPD: identification of measurements related to airway obstruction, airway conductance and lung volumes. Respir Med (2008) 1.19
Safety of indacaterol in the treatment of patients with COPD. Int J Chron Obstruct Pulmon Dis (2011) 1.19
Hypothalamic-pituitary-adrenal stress axis function and the relationship with chronic widespread pain and its antecedents. Arthritis Res Ther (2005) 1.18
A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum (2004) 1.16
Use of gene expression profiling to identify a novel glucocorticoid sensitivity determining gene, BMPRII. FASEB J (2006) 1.15
Independent and parallel lateral transfer of DNA transposons in tetrapod genomes. Gene (2009) 1.12
The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial. Am J Respir Crit Care Med (2014) 1.11
Genetics of sputum gene expression in chronic obstructive pulmonary disease. PLoS One (2011) 1.11
Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretion. J Med Chem (2005) 1.07
Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med (2009) 1.06
The use of plethysmography and oscillometry to compare long-acting bronchodilators in patients with COPD. Br J Clin Pharmacol (2008) 1.06
Identification and functional analysis of SKA2 interaction with the glucocorticoid receptor. J Endocrinol (2008) 1.05
The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD. Eur Respir J (2013) 1.04
Impact factor and its role in academic promotion. Int J Chron Obstruct Pulmon Dis (2009) 1.04
Glucocorticoid ligands specify different interactions with NF-kappaB by allosteric effects on the glucocorticoid receptor DNA binding domain. J Biol Chem (2004) 1.02
Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs. Eur Respir J (2012) 1.02
Cigarette smoke and its component acrolein augment IL-8/CXCL8 mRNA stability via p38 MAPK/MK2 signaling in human pulmonary cells. Am J Physiol Lung Cell Mol Physiol (2012) 0.98
The association between neighbourhood socio-economic status and the onset of chronic widespread pain: results from the EPIFUND study. Eur J Pain (2008) 0.98
The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year. Int J Chron Obstruct Pulmon Dis (2009) 0.98
T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease. Respir Res (2012) 0.97
COPD phenotype description using principal components analysis. Respir Res (2009) 0.97
Non-invasive phenotyping using exhaled volatile organic compounds in asthma. Thorax (2011) 0.97
Human macrophage migration inhibitory factor: a proven immunomodulatory cytokine? J Biol Chem (2006) 0.96
Cigarette smoke extract induced cytokine and chemokine gene expression changes in COPD macrophages. Cytokine (2008) 0.95
The limited distribution of Helitrons to vesper bats supports horizontal transfer. Gene (2010) 0.95
Cunning factor: macrophage migration inhibitory factor as a redox-regulated target. Immunol Cell Biol (2007) 0.95
Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res (2011) 0.95
Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735. Mol Endocrinol (2003) 0.94
Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 0.94
Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers. Analyst (2010) 0.93
Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1/CXCR2. J Pharmacol Exp Ther (2013) 0.93
A comparison of exhaled nitric oxide measurements performed using three different analysers. Respir Med (2006) 0.92
Glucocorticoid receptor gene polymorphisms and susceptibility to rheumatoid arthritis. Clin Endocrinol (Oxf) (2007) 0.91
LPS challenge in healthy subjects: an investigation of neutrophil chemotaxis mechanisms involving CXCR1 and CXCR2. Int Immunopharmacol (2012) 0.91
In vivo imaging of transiently transgenized mice with a bovine interleukin 8 (CXCL8) promoter/luciferase reporter construct. PLoS One (2012) 0.90
Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations. Ther Clin Risk Manag (2008) 0.89
Cigarette smoke and α,β-unsaturated aldehydes elicit VEGF release through the p38 MAPK pathway in human airway smooth muscle cells and lung fibroblasts. Br J Pharmacol (2011) 0.89
Loss of glucocorticoid receptor expression by DNA methylation prevents glucocorticoid induced apoptosis in human small cell lung cancer cells. PLoS One (2011) 0.89
Inhaled LPS challenges in smokers: a study of pulmonary and systemic effects. Br J Clin Pharmacol (2012) 0.88
The effects of dexamethasone on cigarette smoke induced gene expression changes in COPD macrophages. Int Immunopharmacol (2009) 0.87
Reduced glucocorticoid receptor expression and function in airway neutrophils. Int Immunopharmacol (2011) 0.87
Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation. BMC Pulm Med (2011) 0.87
In vitro and in vivo profiling of CHF5022 and CHF5074 Two beta-amyloid1-42 lowering agents. Pharmacol Res (2007) 0.87
Cell cycle phase regulates glucocorticoid receptor function. PLoS One (2011) 0.87
MR Quantitative Equilibrium Signal Mapping: A Reliable Alternative to CT in the Assessment of Emphysema in Patients with Chronic Obstructive Pulmonary Disease. Radiology (2015) 0.86
Acrolein effects in pulmonary cells: relevance to chronic obstructive pulmonary disease. Ann N Y Acad Sci (2012) 0.86
Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells. J Leukoc Biol (2007) 0.85
Down regulation of T cell receptor expression in COPD pulmonary CD8 cells. PLoS One (2013) 0.84
Non-invasive biomarkers and pulmonary function in smokers. Int J Chron Obstruct Pulmon Dis (2008) 0.84
The role of the liver X receptor in chronic obstructive pulmonary disease. Respir Res (2013) 0.83
Novel anti-inflammatory agents in COPD: targeting lung and systemic inflammation. Curr Drug Targets (2013) 0.83
Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum. Respir Res (2014) 0.83
Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease. Br J Clin Pharmacol (2015) 0.82
Point-of-sale alcohol promotions in the Perth and Sydney metropolitan areas. Drug Alcohol Rev (2012) 0.81
CRAC channel inhibition produces greater anti-inflammatory effects than glucocorticoids in CD8 cells from COPD patients. Clin Sci (Lond) (2014) 0.81
The EvA study: aims and strategy. Eur Respir J (2012) 0.81
UbcH7 interacts with the glucocorticoid receptor and mediates receptor autoregulation. J Endocrinol (2006) 0.81
Exhaled volatile organic compounds for phenotyping chronic obstructive pulmonary disease: a cross-sectional study. Respir Res (2012) 0.81
Identification of nuclear protein targets for six leukemogenic tyrosine kinases governed by post-translational regulation. PLoS One (2012) 0.81
Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthma. Respir Res (2007) 0.81
Reduced exhaled breath condensate pH in asthmatic smokers using inhaled corticosteroids. Respirology (2009) 0.80
Corticosteroid insensitive alveolar macrophages from asthma patients; synergistic interaction with a p38 mitogen-activated protein kinase (MAPK) inhibitor. Br J Clin Pharmacol (2015) 0.80
Receptor for advanced glycation end products contributes to postnatal pulmonary development and adult lung maintenance program in mice. Am J Respir Cell Mol Biol (2012) 0.79
Regulation of glucocorticoid receptor gamma (GRgamma) by glucocorticoid receptor haplotype and glucocorticoid. Clin Endocrinol (Oxf) (2004) 0.79
Optimized chemical probes for REV-ERBα. J Med Chem (2013) 0.79
P38 inhibition in COPD; cautious optimism. Thorax (2013) 0.78